ClinicalTrialsFinder

Acute Myeloid Leukemia With Gene Mutations Clinical Trials in Houston, Texas

1 recruitingHouston, Texas

Showing 1–1 of 1 trials

Recruiting
Phase 2

CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Myelodysplastic SyndromeMyeloproliferative NeoplasmRecurrent Acute Myeloid Leukemia+2 more
M.D. Anderson Cancer Center30 enrolled1 locationNCT04493164